• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Pathogenesis of multi drug-resistant and extensively drug-resistant tuberculosis as a determinant of future treatment success.

作者信息

Valafar Faramarz

机构信息

Biomedical Informatics Research Center, Laboratory for Pathogenesis of Clinical Drug Resistance and Persistence, Alvarado Medical Center, San Diego State University, San Diego, CA, USA.

出版信息

Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S64-S65. doi: 10.1016/j.ijmyco.2016.11.017. Epub 2016 Nov 25.

DOI:10.1016/j.ijmyco.2016.11.017
PMID:28043618
Abstract
摘要

相似文献

1
Pathogenesis of multi drug-resistant and extensively drug-resistant tuberculosis as a determinant of future treatment success.耐多药和广泛耐药结核病的发病机制是未来治疗成功的决定因素。
Int J Mycobacteriol. 2016 Dec;5 Suppl 1:S64-S65. doi: 10.1016/j.ijmyco.2016.11.017. Epub 2016 Nov 25.
2
[Extensively drug resistant and extremely drug resistant tuberculosis forms after multi-drug resistant tuberculosis: new faces of the old disease].[广泛耐药和极度耐药结核病在耐多药结核病之后形成：古老疾病的新面貌]
Mikrobiyol Bul. 2011 Jan;45(1):181-95.
3
Management of multidrug-resistant tuberculosis and extensively drug-resistant tuberculosis: current status and future prospects.耐多药结核病和广泛耐药结核病的管理：现状与未来展望
Kekkaku. 2011 Jan;86(1):9-16.
4
Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases.耐多药和广泛耐药结核病病例对二线注射剂的耐药性及治疗结果
Eur Respir J. 2008 Jun;31(6):1155-9. doi: 10.1183/09031936.00028708.
5
Laboratory-Based Surveillance of Extensively Drug-Resistant Tuberculosis in Eastern China.中国东部广泛耐药结核病的实验室监测
Microb Drug Resist. 2017 Mar;23(2):236-240. doi: 10.1089/mdr.2016.0075. Epub 2016 Oct 18.
6
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.耐多药结核病治疗结果与治疗以及初始与获得性二线耐药的关系
Clin Infect Dis. 2016 Feb 15;62(4):418-430. doi: 10.1093/cid/civ910. Epub 2015 Oct 27.
7
Getting personal perspectives on individualized treatment duration in multidrug-resistant and extensively drug-resistant tuberculosis.了解个体化治疗时长在耐多药和广泛耐药结核病中的个人观点。
Am J Respir Crit Care Med. 2014 Aug 15;190(4):374-83. doi: 10.1164/rccm.201402-0363PP.
8
Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.耐多药和广泛耐药结核病（M/XDR-TB）：问题与解决方案
Indian J Tuberc. 2010 Oct;57(4):180-91.
9
Multidrug-resistant tuberculosis: treatment is empirical, for want of robust trials.耐多药结核病：由于缺乏有力的试验，治疗是经验性的。
Prescrire Int. 2014 Oct;23(153):245-6.
10
Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.预测耐多药和广泛耐药结核病复发的因素。
Int J Tuberc Lung Dis. 2012 Sep;16(9):1228-33. doi: 10.5588/ijtld.12.0037. Epub 2012 Jun 28.

引用本文的文献

1
Application of ultrasound multimodal imaging in the prediction of cervical tuberculous lymphadenitis rupture.超声多模态成像在预测颈淋巴结结核破裂中的应用。
Epidemiol Infect. 2024 Jan 30;152:e28. doi: 10.1017/S0950268824000153.
2
Percutaneous ultrasound-guided laser ablation for the treatment of cervical tuberculous lymphadenitis: a pilot study.经皮超声引导下激光消融治疗颈部结核性淋巴结炎：一项初步研究。
J Int Med Res. 2019 Apr;47(4):1512-1520. doi: 10.1177/0300060518821818. Epub 2019 Jan 11.